“…However, several anastomoses connecting the MMA with the OA were used for drug delivery: the direct anastomosis between the 2 vessels (meningo-ophthalmic artery) was used in 14 eyes (38 sessions); the anastomosis between the MMA and the lacrimal artery was used in 9 orbits (24 sessions); and finally, in 1 orbit (2 sessions), we used an unusual anastomosis between the MMA and the supraorbital artery. 12 Less frequently, the arteries used for delivering the antitumoral drugs were periorbital vessels that anastomosed with arteries running in the anterior orbit and were identified following previously published criteria, 13 such as the dorsal nasal artery anastomosed with the angular artery (1 eye, 1 session), 12 the frontal branch of the superficial temporal artery that anastomosed with the supratrochlear artery (1 eye, 1 session), 12 the zygomatico-orbital artery anastomosed with the lacrimal artery (1 eye, 2 sessions), 12 and the anterior deep temporal artery connected to the lacrimal artery (3 eyes, 5 sessions). 12 Seven patients (7 eyes affected by grade D tumors) abandoned the treatment after just 1 session (1 patient treated via a branch of the ECA and 6 via the OA).…”